BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6576318)

  • 1. [The use of medium- and high-dose methotrexate in the management of malignant childhood diseases].
    Nagy K; Hunyadi K; Velkey L
    Orv Hetil; 1983 Jun; 124(24):1433-9. PubMed ID: 6576318
    [No Abstract]   [Full Text] [Related]  

  • 2. Mega doses of methotrexate in the treatment of osteosarcoma.
    Iqbal MP; Malik IA
    J Pak Med Assoc; 1990 Oct; 40(10):248-51. PubMed ID: 2123265
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient case involving high-dose methotrexate followed by leucovorin rescue.
    Alsop JA
    Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with high-dose methotrexate therapy for malignant solid tumors].
    Kawai K; Shibata T; Azuma E; Arai S; Nakano C; Hirai S; Kazuoka K; Komada Y; Nakabayashi T; Hirota H; Matsuda T; Shimizu S; Nobori T; Inoue M; Kamiya H; Sakurai M; Ogiwara T; Kawabe Y; Nomura T; Kato M; Uejima A
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):263-8. PubMed ID: 6964035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of IV hydration with sodium bicarbonate on high-dose methotrexate disposition kinetics].
    Tsuda N; Goto M; Konishi H; Yamashina H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):873-80. PubMed ID: 6326682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High dosage of Methotrexate in childhood malignancy].
    Moe PJ; Gutteberg TJ
    Tidsskr Nor Laegeforen; 1976 Jun; 96(17-18):997-9. PubMed ID: 1065788
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.
    Rosen G; Nirenberg A
    Cancer Treat Rep; 1982 Sep; 66(9):1687-97. PubMed ID: 6981454
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of heterologous immune globulins upon human cancer in vivo.
    Sekla B; Holecková E; Janele J; Libánský J; Hnĕvkovský O
    Neoplasma; 1967; 14(6):641-7. PubMed ID: 4169507
    [No Abstract]   [Full Text] [Related]  

  • 10. Femur replacement.
    Staudt AR
    Am J Nurs; 1975 Aug; 75(8):1346-8. PubMed ID: 1080013
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate-induced bullous acral erythema in a child.
    Werchniak AE; Chaffee S; Dinulos JG
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for osteosarcoma at the Singapore General Hospital.
    Khor TH; Chua EJ; Tan BC; Chia KB
    Singapore Med J; 1983 Apr; 24(2):95-8. PubMed ID: 6577611
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC
    Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma.
    Pratt CB; Howarth C; Ransom JL; Bowles D; Green AA; Kumar AP; Rivera G; Evans WE
    Cancer Treat Rep; 1980 Jan; 64(1):11-20. PubMed ID: 6966535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
    Yamada K; Takahashi M; Yoshida M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of high-dose methotrexate in patients with unresectable metastatic osteosarcoma.
    Edmonson JH; Creagan ET; Gilchrist GS
    Cancer Treat Rep; 1981; 65(5-6):538-9. PubMed ID: 6972255
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myeloblastic leukemia in children].
    Sroczyńska M; Sońta-Jakimczyk D; Mazur H
    Pediatr Pol; 1982 Dec; 57(12):1015-21. PubMed ID: 6963629
    [No Abstract]   [Full Text] [Related]  

  • 19. Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy.
    Iqbal MP; Malik I; Mehboobali N
    J Pak Med Assoc; 1992 Aug; 42(8):193-6. PubMed ID: 1433799
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW; Knowling MA; Duncan CP; Morton KS
    Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.